In the US, Aztreonam (aztreonam systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Bacteremia, Bacterial Infection, Bone infection, Cystic Fibrosis, Febrile Neutropenia, Intraabdominal Infection, Kidney Infections, Pelvic Inflammatory Disease, Peritonitis, Pneumonia, Pneumonia with Cystic Fibrosis, Skin and Structure Infection, Skin Infection and Urinary Tract Infection.
US matches:
- Aztreonam
- Aztreonam inhalation
- Aztreonam injection
- Aztreonam Intravenous, Injection
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J01DF01
CAS registry number (Chemical Abstracts Service)
0078110-38-0
Chemical Formula
C13-H17-N5-O8-S2
Molecular Weight
435
Therapeutic Category
Antibacterial
Chemical Name
Propanoic acid, 2-[[[1-(2-amino-4-thiazolyl)-2-[(2-methyl-4-oxo-1-sulfo-3-azetidinyl)amino]-2-oxoethylidene]amino]oxy]-2-methyl-, [2S-[2α,3ß(Z)]]-
Foreign Names
- Aztreonamum (Latin)
- Aztreonam (German)
- Aztréonam (French)
- Aztreonam (Spanish)
Generic Names
- Aztreonam (OS: DCIT, USAN, BAN)
- Aztréonam (OS: DCF)
- SQ 26776 (IS: Squibb)
- Aztreonam (PH: JP XV, USP 32)
Brand Names
- Azactam
Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Bahrain; Bristol-Myers Squibb, Brazil; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Spain; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Greece; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Kenya; Bristol-Myers Squibb, Luxembourg; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Oman; Bristol-Myers Squibb, Peru; Bristol-Myers Squibb, Philippines; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, Tanzania; Bristol-Myers Squibb, Uganda; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, Venezuela; Bristol-Myers Squibb, South Africa; Eisai, Japan; Elan, United States; Sanofi-Aventis, France
- Azenam
Aristo, India
- Aztreonam
Richet, Argentina; Vitalis, Peru; Vitalis, Venezuela
- Cayston
Gilead, Canada; Gilead, Germany; Gilead, United Kingdom; Gilead, Ireland; Gilead, Netherlands; Gilead, United States
- Primbactam
Menarini, Italy
- Vebac
Fahrenheit, Indonesia
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.